Clinical Trial Update: Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating the efficacy and safety of VC005 tablets for non-segmental vitiligo is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-segmental Vitiligo

Drugs mentioned

• VC005

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Non-segmental Vitiligo | Phase 2 | Status: RECRUITING